To be eligible for the scholarship, applicants must be enrolled in a PhD program at the University of Newcastle with a research focus on Alzheimer’s Disease. Both full-time and part-time students are eligible, and the scholarship is open to Australian Citizens, Permanent Residents, and International Students.
Established in 1965, the University of Newcastle (UON) is a public university in Newcastle, New South Wales, Australia. With over 37,000 students, it offers a diverse range of programs across five faculties, including engineering, health, business, and creative industries. Known for its strong research focus, UON ranks in the top 200 globally and emphasizes innovation, sustainability, and community engagement.
Application Deadline: 30 May 2025
Brief Description
- University or Organization: University of Newcastle
- Department: NA
- Course Level: PhD
- Award: One-off lump sum payment of $8,000
- Access Mode: Online
- Number of Awards: NA
- Nationality: Domestic and International students
- The award can be taken in: Australia
Eligibility
- Eligible Countries: All nationalities
- Acceptable Course or Subjects: The scholarship will be awarded for research related to Alzheimer’s Disease
- Admissible Criteria: To be eligible, the applicants must meet all the following criteria:
- Be enrolled in a PhD program within the Alzheimer’s Disease research area at the University of Newcastle.
- Be enrolled full-time or part-time.
- Be an Australian Citizen, Permanent Resident, or International Student.
To apply for this scholarship, candidates must submit the following documents:
- A curriculum vitae
- A written statement (no more than 1 A4 page excluding evidence) outlining research progress, future plans, and aspirations
- A supporting letter from your supervisor
- Agree to the terms and conditions regarding privacy as outlined in the Declaration and Authority section of the application
Submit your application via email to: [email protected]
Benefits
The successful recipient will receive a one-off payment of AUD $8,000 to support their research in Alzheimer’s Disease.
